Learn More
Medchemexpress LLC JI-101 | 900573-88-8 | 99.0% | 466.33 | 5 MG

Supplier: Medchemexpress LLC HY162655MG
JI-101 is an orally available multi-kinase inhibitor of VEGFR2, PDGFRβ, and EphB4 with potent anti-cancer activity. It is for research use only and is not sold to patients.
- Orally available multi-kinase inhibitor.
- Inhibits VEGFR2, PDGFRβ, and EphB4.
- Potent anti-cancer activity.
- Stable in all preclinical and human liver microsomes.
- Rapidly absorbed after oral administration, reaching Cmax within 2 hours.
- Extensive tissue distribution with rapid and preferred uptake into lung tissue.
- Oral bioavailability is 55%.
- Primary route of elimination is feces.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.